Status:
COMPLETED
Effects of Citalopram on Hostility and CHD Risk
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
To evaluate the therapeutic effects of the serotonergic agent, citalopram, on hostility and other behavioral risk factors, and biological markers of disease risk (serum lipids, insulin and glucose; au...
Detailed Description
BACKGROUND: Hostility, a broad personality dimension comprised of behavioral tendencies, cognitive biases and emotional or motivational characteristics appears to play an important role in the develo...
Eligibility Criteria
Inclusion
- No eligibility criteria
Exclusion
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
February 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00217828
Start Date
March 1 2002
End Date
February 1 2003
Last Update
June 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.